PARK16 Rs708730 Polymorphism Decreases Parkinson’s Disease Risk in European Ancestry Population: a Meta-Analysis
Zhijie Han,Baochu Wei,Chenghong Zhang,Hongtian Zhu,Lei Tang,Ruili Lin,Dian He,Yang ZHANG,Pingrong Yang,Junquan He,Pingshun Song
DOI: https://doi.org/10.30564/jgm.v1i2.798
2020-01-01
Journal of Geriatric Medicine
Abstract:Parkinson’s disease (PD) is a complex fatal chronic neurodegenerative disease most common in elderly people. The early genome-wide association studies (GWAS) found that the minor allele variant of PARK16 rs708730 polymorphism is a significant protective factor for PD in Caucasian populations. However, these results cannot be repeated by the following studies in Caucasian populations and other populations. We considered that the inconsistency of the findings may be caused by the small-scale samples or the heterogeneity among different populations. Therefore, in this study, we synthesized the previous related GWAS studies through three authoritative sources, and used the large-scale samples (10,645 PD cases and 30,499 controls) to reevaluate the association between rs708730 polymorphism and PD. The results showed that there is no association between them in Asian ancestry population. While, in European ancestry population, we found that the minor allele variant (G) of rs708730 polymorphism is significantly associated with a decreased risk of PD. Collectively, our findings further verified the association of rs708730 with PD and show its genetic heterogeneity among different populations, which can help to develop a better understanding of the PD’s pathogenesis.
What problem does this paper attempt to address?